Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 57,879 | 48,193 | 62,870 | 55,132 | 50,347 |
| Operating Income | -57,879 | -48,193 | -62,870 | -55,132 | -50,347 |
| Other Income | -1,325 | 88 | 51,681 | 115 | 99 |
| Pre-tax Income | -59,204 | -48,105 | -11,189 | -55,017 | -50,248 |
| Income Tax | 33 | 159 | -697 | 45 | 196 |
| Net Income Continuous | -59,237 | -50,095 | -10,492 | -55,062 | -50,444 |
| Minority Interests | -160 | -36 | -6,301 | -488 | -543 |
| Net Income | $-59,077 | $-50,059 | $-4,191 | $-54,574 | $-49,901 |
| EPS Basic Total Ops | -1.31 | -1.05 | -0.09 | -1.34 | -1.24 |
| EPS Basic Continuous Ops | -1.31 | -1.05 | -0.24 | -1.35 | -1.25 |
| EPS Diluted Total Ops | -1.31 | -1.05 | -0.09 | -1.34 | -1.24 |
| EPS Diluted Continuous Ops | -1.31 | -1.05 | -0.24 | -1.35 | -1.25 |
| EBITDA(a) | $-57,389 | $-47,788 | $-62,542 | $-54,781 | $-49,979 |